STOCK TITAN
  1. Home
  2. Sec-filings
  3. ELAN
  4. [Form 4] Elanco Animal Health Inc Insider Trading Activity

Elanco (ELAN) CEO Jeffrey Simmons receives 4,497 deferred stock units grant

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc President and CEO Jeffrey N. Simmons received a grant of 4,497.6194 deferred stock units linked to the company’s common stock. Each unit represents the right to receive one share of common stock or the cash equivalent in the future, typically after employment ends or in a specified year. Following this award, his reported deferred stock unit balance is 23,677.3833 units, reflecting compensation rather than an open-market stock purchase or sale.

Positive

  • None.

Negative

  • None.

Insights

Routine deferred stock unit award to Elanco’s CEO, no open-market trading.

The filing shows CEO Jeffrey N. Simmons received 4,497.6194 deferred stock units tied to Elanco Animal Health Inc common stock at a reference value of $23.3600 per unit. This is coded as an acquisition via grant or award, not a market transaction.

The units represent a right to future shares or cash and settle after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan. There are no remaining derivative positions listed, and total reported deferred units are 23,677.3833 after the grant.

Because this is standard equity-based compensation with no open-market buying or selling, it is generally viewed as an administrative update rather than a directional signal about the stock. The economic impact depends on Elanco’s share price and the eventual settlement terms when employment ends or the chosen deferral year arrives.

Insider Simmons Jeffrey N
Role PRESIDENT, CEO AND DIRECTOR
Type Security Shares Price Value
Grant/Award Deferred Stock Units 4,497.6194 $23.36 $105K
Holdings After Transaction: Deferred Stock Units — 23,677.3833 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Elanco (ELAN) report for Jeffrey N. Simmons?
Elanco reported that CEO Jeffrey N. Simmons received 4,497.6194 deferred stock units as a compensation grant. These units are linked to Elanco common stock and increase his total reported deferred stock units to 23,677.3833, without involving any open-market share purchases or sales.

Is the Elanco (ELAN) Form 4 a stock purchase or sale by the CEO?
The Form 4 does not show a stock purchase or sale by the CEO. It reports a grant of deferred stock units as compensation, coded as an acquisition by award, rather than an open-market trade, so it reflects pay structure rather than active trading in Elanco shares.

How many deferred stock units does the Elanco (ELAN) CEO hold after this grant?
After receiving 4,497.6194 new deferred stock units, CEO Jeffrey N. Simmons is reported to hold 23,677.3833 deferred stock units. These represent future rights to Elanco common stock or cash, not currently outstanding common shares directly tradable in the market.

What are deferred stock units in the Elanco (ELAN) executive plan?
Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. Under the Executive Deferral and Stock Match Plan, these units typically settle in cash or shares after employment ends or in a specified future year chosen under the plan.

At what value were the Elanco (ELAN) deferred stock units granted to the CEO?
The 4,497.6194 deferred stock units granted to CEO Jeffrey N. Simmons reference a value of $23.3600 per unit. This value is used for the award calculation and does not represent an open-market trade price, since the units are a deferred compensation instrument.

Does the Elanco (ELAN) Form 4 indicate any remaining derivative positions for the CEO?
The filing shows a single derivative transaction in deferred stock units and no listed remaining derivative positions. After this grant, the reported balance of deferred stock units is 23,677.3833, reflecting his current holdings in this specific compensation-related instrument.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Simmons Jeffrey N
(Last) (First) (Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE
(Street)
INDIANAPOLIS IN 46221
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT, CEO AND DIRECTOR
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 03/06/2026 A 4,497.6194 (2) (2) Common Stock 4,497.6194 $23.36 23,677.3833 D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR